Gilder Gagnon Howe & Co’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,206
| Closed | -$1.58M | – | 263 |
|
|
2024
Q3 | $1.58M | Sell |
23,206
-425
| -2% | -$24K | 0.02% | 193 |
|
|
2024
Q2 | $998K | Sell |
23,631
-420
| -2% | -$23.1K | 0.01% | 206 |
|
|
2024
Q1 | $1.66M | Sell |
24,051
-121,951
| -84% | -$7.71M | 0.02% | 194 |
|
|
2023
Q4 | $10.8M | Sell |
146,002
-32,433
| -18% | -$2.13M | 0.15% | 114 |
|
|
2023
Q3 | $12.2M | Sell |
178,435
-200
| -0.1% | -$17K | 0.19% | 102 |
|
|
2023
Q2 | $16.8M | Buy |
178,635
+36,120
| +25% | +$2.82M | 0.23% | 91 |
|
|
2023
Q1 | $9.66M | Buy |
142,515
+1,374
| +1% | +$88.3K | 0.16% | 112 |
|
|
2022
Q4 | $6.99M | Buy |
141,141
+9,083
| +7% | +$371K | 0.13% | 121 |
|
|
2022
Q3 | $4.29M | Sell |
132,058
-494,925
| -79% | -$20.4M | 0.07% | 139 |
|
|
2022
Q2 | $24.7M | Sell |
626,983
-757,613
| -55% | -$40.5M | 0.44% | 64 |
|
|
2022
Q1 | $96.8M | Sell |
1,384,596
-24,076
| -2% | -$1.76M | 0.89% | 31 |
|
|
2021
Q4 | $110M | Sell |
1,408,672
-17,217
| -1% | -$1.52M | 0.62% | 53 |
|
|
2021
Q3 | $136M | Sell |
1,425,889
-19,489
| -1% | -$2.06M | 0.71% | 45 |
|
|
2021
Q2 | $180M | Sell |
1,445,378
-23,423
| -2% | -$2.8M | 0.88% | 30 |
|
|
2021
Q1 | $194M | Buy |
1,468,801
+119,772
| +9% | +$16.4M | 1.04% | 23 |
|
|
2020
Q4 | $179M | Sell |
1,349,029
-13,819
| -1% | -$1.67M | 0.89% | 28 |
|
|
2020
Q3 | $139M | Sell |
1,362,848
-42,178
| -3% | -$3.64M | 0.86% | 28 |
|
|
2020
Q2 | $122M | Sell |
1,405,026
-157,010
| -10% | -$12.5M | 0.96% | 28 |
|
|
2020
Q1 | $90.6M | Sell |
1,562,036
-188,173
| -11% | -$15.3M | 1.09% | 21 |
|
|
2019
Q4 | $162M | Sell |
1,750,209
-51,885
| -3% | -$4.56M | 1.68% | 9 |
|
|
2019
Q3 | $163M | Sell |
1,802,094
-86,193
| -5% | -$9.82M | 1.87% | 8 |
|
|
2019
Q2 | $223M | Sell |
1,888,287
-117,107
| -6% | -$11.8M | 2.25% | 5 |
|
|
2019
Q1 | $174M | Buy |
2,005,394
+107,603
| +6% | +$9.16M | 1.85% | 10 |
|
|
2018
Q4 | $120M | Sell |
1,897,791
-51,189
| -3% | -$3.51M | 1.7% | 9 |
|
|
2018
Q3 | $154M | Sell |
1,948,980
-21,009
| -1% | -$1.37M | 1.57% | 12 |
|
|
2018
Q2 | $118M | Sell |
1,969,989
-30,048
| -2% | -$1.62M | 1.27% | 19 |
|
|
2018
Q1 | $80.7M | Sell |
2,000,037
-95,161
| -5% | -$4.64M | 1% | 28 |
|
|
2017
Q4 | $110M | Sell |
2,095,198
-444,254
| -17% | -$23.7M | 1.48% | 16 |
|
|
2017
Q3 | $120M | Sell |
2,539,452
-589,163
| -19% | -$23.7M | 1.68% | 11 |
|
|
2017
Q2 | $111M | Sell |
3,128,615
-59,180
| -2% | -$1.83M | 1.64% | 9 |
|
|
2017
Q1 | $75.3M | Sell |
3,187,795
-525,056
| -14% | -$10.4M | 1.27% | 18 |
|
|
2016
Q4 | $49.6M | Sell |
3,712,851
-187,449
| -5% | -$3.03M | 0.98% | 28 |
|
|
2016
Q3 | $72.4M | Buy |
3,900,300
+2,287,290
| +142% | +$40.3M | 1.25% | 19 |
|
|
2016
Q2 | $19.8M | Sell |
1,613,010
-1,747,116
| -52% | -$13.2M | 0.39% | 66 |
|
|
2016
Q1 | $22.6M | Sell |
3,360,126
-26,150
| -0.8% | -$167K | 0.44% | 53 |
|
|
2015
Q4 | $31.3M | Sell |
3,386,276
-147,289
| -4% | -$1.37M | 0.5% | 50 |
|
|
2015
Q3 | $63.6M | Sell |
3,533,565
-35,305
| -1% | -$811K | 1.01% | 28 |
|
|
2015
Q2 | $106M | Buy |
3,568,870
+35,156
| +1% | +$883K | 1.39% | 23 |
|
|
2015
Q1 | $77.8M | Sell |
3,533,714
-47,309
| -1% | -$1.2M | 1.08% | 27 |
|
|
2014
Q4 | $98.3M | Sell |
3,581,023
-5,449
| -0.2% | -$133K | 1.46% | 21 |
|
|
2014
Q3 | $69.5M | Sell |
3,586,472
-927,545
| -21% | -$17M | 1.01% | 27 |
|
|
2014
Q2 | $76.9M | Sell |
4,514,017
-39,037
| -0.9% | -$537K | 1.02% | 25 |
|
|
2014
Q1 | $64.5M | Buy |
4,553,054
+689,295
| +18% | +$9.31M | 0.88% | 33 |
|
|
2013
Q4 | $45.4M | Sell |
3,863,759
-33,239
| -0.9% | -$381K | 0.65% | 47 |
|
|
2013
Q3 | $46M | Sell |
3,896,998
-25,508
| -0.7% | -$327K | 0.72% | 47 |
|
|
2013
Q2 | $54.6M | Buy |
+3,922,506
| New | +$42.6M | 1.03% | 33 |
|
Other funds holding EXAS
Gilder Gagnon Howe & Co's EXAS Position: Q4 2024 in Review
Gilder Gagnon Howe & Co sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 23,206 shares — an estimated $1.58M sold.
Gilder Gagnon Howe & Co first reported a position in EXAS in Q2 2013 and held it in 46 quarters. The position peaked at $223M in Q2 2019. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.
- Gilder Gagnon Howe & Co reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
- Gilder Gagnon Howe & Co sold 23,206 Exact Sciences shares in Q4 2024, an estimated $1.58M.
- Gilder Gagnon Howe & Co first reported a position in Exact Sciences in Q2 2013 and held it in 46 quarters.
- Gilder Gagnon Howe & Co's Exact Sciences position peaked at $223M in Q2 2019.
- 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.
Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2024, filed 14 Feb 2025.